APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccines

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Selected research

Industry Research

Oral Vaccines Industry Research Report 2026

2 January 2026138 pages

Choose your research edition.

Industry ResearchOral Vaccines Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccines Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccines Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.

Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.

Read the full market overview

Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.

Report Scope

This report quantifies the global Oral Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oral Vaccines Market by Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Oral Vaccines Segment by Type

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Oral Vaccines Segment by Application

Public

Private

Oral Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oral Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oral Vaccines Sales (M Doses) of Manufacturers (2021-2026) Table 7. Global Oral Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oral Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Oral Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oral Vaccines Average Price (USD/K Doses) of Manufacturers (2021-2026) Table 11. Global Oral Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oral Vaccines, Product Type & Application Table 14. Global Oral Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oral Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck Company Information Table 19. Merck Business Overview Table 20. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 21. Merck Oral Vaccines Product Portfolio Table 22. Merck Recent Developments Table 23. GSK Company Information Table 24. GSK Business Overview Table 25. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 26. GSK Oral Vaccines Product Portfolio Table 27. GSK Recent Developments Table 28. Sanofi Company Information Table 29. Sanofi Business Overview Table 30. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 31. Sanofi Oral Vaccines Product Portfolio Table 32. Sanofi Recent Developments Table 33. Lanzhou Institute Company Information Table 34. Lanzhou Institute Business Overview Table 35. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 36. Lanzhou Institute Oral Vaccines Product Portfolio Table 37. Lanzhou Institute Recent Developments Table 38. Serum Institute Company Information Table 39. Serum Institute Business Overview Table 40. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 41. Serum Institute Oral Vaccines Product Portfolio Table 42. Serum Institute Recent Developments Table 43. Valneva Company Information Table 44. Valneva Business Overview Table 45. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 46. Valneva Oral Vaccines Product Portfolio Table 47. Valneva Recent Developments Table 48. Shanghai United Cell Company Information Table 49. Shanghai United Cell Business Overview Table 50. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 51. Shanghai United Cell Oral Vaccines Product Portfolio Table 52. Shanghai United Cell Recent Developments Table 53. Bibcol Company Information Table 54. Bibcol Business Overview Table 55. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 56. Bibcol Oral Vaccines Product Portfolio Table 57. Bibcol Recent Developments Table 58. PaxVax Company Information Table 59. PaxVax Business Overview Table 60. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 61. PaxVax Oral Vaccines Product Portfolio Table 62. PaxVax Recent Developments Table 63. Vabiotech Company Information Table 64. Vabiotech Business Overview Table 65. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 66. Vabiotech Oral Vaccines Product Portfolio Table 67. Vabiotech Recent Developments Table 68. Tiantan Biological Company Information Table 69. Tiantan Biological Business Overview Table 70. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 71. Tiantan Biological Oral Vaccines Product Portfolio Table 72. Tiantan Biological Recent Developments Table 73. EuBiologics Company Information Table 74. EuBiologics Business Overview Table 75. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 76. EuBiologics Oral Vaccines Product Portfolio Table 77. EuBiologics Recent Developments Table 78. Panacea Biotec Ltd Company Information Table 79. Panacea Biotec Ltd Business Overview Table 80. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 81. Panacea Biotec Ltd Oral Vaccines Product Portfolio Table 82. Panacea Biotec Ltd Recent Developments Table 83. Bio-Med Company Information Table 84. Bio-Med Business Overview Table 85. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 86. Bio-Med Oral Vaccines Product Portfolio Table 87. Bio-Med Recent Developments Table 88. Halfkin Bio-Pharmaceuticals Company Information Table 89. Halfkin Bio-Pharmaceuticals Business Overview Table 90. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 91. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio Table 92. Halfkin Bio-Pharmaceuticals Recent Developments Table 93. Global Oral Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Oral Vaccines Sales by Region (2021-2026) & (M Doses) Table 95. Global Oral Vaccines Sales Market Share by Region (2021-2026) Table 96. Global Oral Vaccines Sales by Region (2027-2032) & (M Doses) Table 97. Global Oral Vaccines Sales Market Share by Region (2027-2032) Table 98. Global Oral Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Oral Vaccines Revenue Market Share by Region (2021-2026) Table 100. Global Oral Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Oral Vaccines Revenue Market Share by Region (2027-2032) Table 102. North America Oral Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 104. North America Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 105. North America Oral Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Oral Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Oral Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 109. Europe Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 110. Europe Oral Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Oral Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Oral Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 114. Asia Pacific Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 115. Asia Pacific Oral Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Oral Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Oral Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 119. South America Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 120. South America Oral Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Oral Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Oral Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 124. Middle East and Africa Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 125. Middle East and Africa Oral Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Oral Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 128. Global Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 129. Global Oral Vaccines Sales Market Share by Type (2021-2026) Table 130. Global Oral Vaccines Sales Market Share by Type (2027-2032) Table 131. Global Oral Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Oral Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Oral Vaccines Revenue Market Share by Type (2021-2026) Table 134. Global Oral Vaccines Revenue Market Share by Type (2027-2032) Table 135. Global Oral Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 136. Global Oral Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 137. Global Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 138. Global Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 139. Global Oral Vaccines Sales Market Share by Application (2021-2026) Table 140. Global Oral Vaccines Sales Market Share by Application (2027-2032) Table 141. Global Oral Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Oral Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Oral Vaccines Revenue Market Share by Application (2021-2026) Table 144. Global Oral Vaccines Revenue Market Share by Application (2027-2032) Table 145. Global Oral Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 146. Global Oral Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Oral Vaccines Distributors List Table 150. Oral Vaccines Customers List Table 151. Oral Vaccines Industry Trends Table 152. Oral Vaccines Industry Drivers Table 153. Oral Vaccines Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oral Vaccines Product Image Figure 5. Global Oral Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oral Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Oral Vaccines Sales (2021-2032) & (M Doses) Figure 8. Global Oral Vaccines Average Price (USD/K Doses) & (2021-2032) Figure 9. Rotavirus Vaccine Product Image Figure 10. Cholera Vaccine Product Image Figure 11. Oral Polio Vaccine Product Image Figure 12. Public Product Image Figure 13. Private Product Image Figure 14. Global Oral Vaccines Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Oral Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Oral Vaccines Sales by Region in 2025 Figure 20. Global Oral Vaccines Revenue by Region in 2025 Figure 21. North America Oral Vaccines Market Size by Country in 2025 Figure 22. North America Oral Vaccines Sales Market Share by Country (2021-2032) Figure 23. North America Oral Vaccines Revenue Market Share by Country (2021-2032) Figure 24. United States Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Oral Vaccines Market Size by Country in 2025 Figure 28. Europe Oral Vaccines Sales Market Share by Country (2021-2032) Figure 29. Europe Oral Vaccines Revenue Market Share by Country (2021-2032) Figure 30. Germany Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Oral Vaccines Market Size by Country in 2025 Figure 41. Asia Pacific Oral Vaccines Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Oral Vaccines Revenue Market Share by Country (2021-2032) Figure 43. China Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Oral Vaccines Market Size by Country in 2025 Figure 52. South America Oral Vaccines Sales Market Share by Country (2021-2032) Figure 53. South America Oral Vaccines Revenue Market Share by Country (2021-2032) Figure 54. Brazil Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Oral Vaccines Market Size by Country in 2025 Figure 59. Middle East and Africa Oral Vaccines Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Oral Vaccines Revenue Market Share by Country (2021-2032) Figure 61. Egypt Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Oral Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Oral Vaccines Sales Market Share by Type (2021-2032) Figure 67. Global Oral Vaccines Revenue Market Share by Type (2021-2032) Figure 68. Global Oral Vaccines Price (USD/K Doses) by Type (2021-2032) Figure 69. Global Oral Vaccines Sales Market Share by Application (2021-2032) Figure 70. Global Oral Vaccines Revenue Market Share by Application (2021-2032) Figure 71. Global Oral Vaccines Price (USD/K Doses) by Application (2021-2032) Figure 72. Oral Vaccines Value Chain Figure 73. Oral Vaccines Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Oral Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Cholera Vaccine
  • Oral Polio Vaccine
Applications
  • Public
  • Private
Companies covered
  • Merck
  • GSK
  • Sanofi
  • Lanzhou Institute
  • Serum Institute
  • Valneva
  • Shanghai United Cell
  • Bibcol
  • PaxVax
  • Vabiotech
  • Tiantan Biological
  • EuBiologics
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oral Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Oral Vaccines Sales (2021-2032)
  5. 2.2.3 Global Oral Vaccines Market Average Price (2021-2032)
  6. 2.3 Oral Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Rotavirus Vaccine
  9. 2.3.3 Cholera Vaccine
  10. 2.3.4 Oral Polio Vaccine
  11. 2.4 Oral Vaccines by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Public
  14. 2.4.3 Private
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oral Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oral Vaccines Sales (M Doses) of Manufacturers (2021-2026)
  3. 3.3 Global Oral Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oral Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oral Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oral Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Oral Vaccines, Established Date
  9. 3.9 Global Oral Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck
  2. 4.1.1 Merck Company Information
  3. 4.1.2 Merck Business Overview
  4. 4.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck Oral Vaccines Product Portfolio
  6. 4.1.5 Merck Recent Developments
  7. 4.2 GSK
  8. 4.2.1 GSK Company Information
  9. 4.2.2 GSK Business Overview
  10. 4.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 GSK Oral Vaccines Product Portfolio
  12. 4.2.5 GSK Recent Developments
  13. 4.3 Sanofi
  14. 4.3.1 Sanofi Company Information
  15. 4.3.2 Sanofi Business Overview
  16. 4.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sanofi Oral Vaccines Product Portfolio
  18. 4.3.5 Sanofi Recent Developments
  19. 4.4 Lanzhou Institute
  20. 4.4.1 Lanzhou Institute Company Information
  21. 4.4.2 Lanzhou Institute Business Overview
  22. 4.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
  24. 4.4.5 Lanzhou Institute Recent Developments
  25. 4.5 Serum Institute
  26. 4.5.1 Serum Institute Company Information
  27. 4.5.2 Serum Institute Business Overview
  28. 4.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Serum Institute Oral Vaccines Product Portfolio
  30. 4.5.5 Serum Institute Recent Developments
  31. 4.6 Valneva
  32. 4.6.1 Valneva Company Information
  33. 4.6.2 Valneva Business Overview
  34. 4.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Valneva Oral Vaccines Product Portfolio
  36. 4.6.5 Valneva Recent Developments
  37. 4.7 Shanghai United Cell
  38. 4.7.1 Shanghai United Cell Company Information
  39. 4.7.2 Shanghai United Cell Business Overview
  40. 4.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
  42. 4.7.5 Shanghai United Cell Recent Developments
  43. 4.8 Bibcol
  44. 4.8.1 Bibcol Company Information
  45. 4.8.2 Bibcol Business Overview
  46. 4.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Bibcol Oral Vaccines Product Portfolio
  48. 4.8.5 Bibcol Recent Developments
  49. 4.9 PaxVax
  50. 4.9.1 PaxVax Company Information
  51. 4.9.2 PaxVax Business Overview
  52. 4.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 PaxVax Oral Vaccines Product Portfolio
  54. 4.9.5 PaxVax Recent Developments
  55. 4.10 Vabiotech
  56. 4.10.1 Vabiotech Company Information
  57. 4.10.2 Vabiotech Business Overview
  58. 4.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Vabiotech Oral Vaccines Product Portfolio
  60. 4.10.5 Vabiotech Recent Developments
  61. 4.11 Tiantan Biological
  62. 4.11.1 Tiantan Biological Company Information
  63. 4.11.2 Tiantan Biological Business Overview
  64. 4.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Tiantan Biological Oral Vaccines Product Portfolio
  66. 4.11.5 Tiantan Biological Recent Developments
  67. 4.12 EuBiologics
  68. 4.12.1 EuBiologics Company Information
  69. 4.12.2 EuBiologics Business Overview
  70. 4.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 EuBiologics Oral Vaccines Product Portfolio
  72. 4.12.5 EuBiologics Recent Developments
  73. 4.13 Panacea Biotec Ltd
  74. 4.13.1 Panacea Biotec Ltd Company Information
  75. 4.13.2 Panacea Biotec Ltd Business Overview
  76. 4.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
  78. 4.13.5 Panacea Biotec Ltd Recent Developments
  79. 4.14 Bio-Med
  80. 4.14.1 Bio-Med Company Information
  81. 4.14.2 Bio-Med Business Overview
  82. 4.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bio-Med Oral Vaccines Product Portfolio
  84. 4.14.5 Bio-Med Recent Developments
  85. 4.15 Halfkin Bio-Pharmaceuticals
  86. 4.15.1 Halfkin Bio-Pharmaceuticals Company Information
  87. 4.15.2 Halfkin Bio-Pharmaceuticals Business Overview
  88. 4.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
  90. 4.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
5 Global Oral Vaccines Market Scenario by Region
  1. 5.1 Global Oral Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oral Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Oral Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Oral Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Oral Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Oral Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Oral Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Oral Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oral Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Oral Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Oral Vaccines Market Facts & Figures by Country
  16. 5.5.1 Europe Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Oral Vaccines Sales by Country (2021-2032)
  18. 5.5.3 Europe Oral Vaccines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Oral Vaccines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Oral Vaccines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Oral Vaccines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Oral Vaccines Market Facts & Figures by Country
  41. 5.7.1 South America Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Oral Vaccines Sales by Country (2021-2032)
  43. 5.7.3 South America Oral Vaccines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Oral Vaccines Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Oral Vaccines Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Oral Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Oral Vaccines Sales by Type (2021-2032) & (M Doses)
  3. 6.1.2 Global Oral Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oral Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Oral Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oral Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oral Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oral Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Oral Vaccines Sales by Application (2021-2032) & (M Doses)
  3. 7.1.2 Global Oral Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oral Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Oral Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oral Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oral Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oral Vaccines Value Chain Analysis
  2. 8.1.1 Oral Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oral Vaccines Production Mode & Process
  5. 8.2 Oral Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oral Vaccines Distributors
  8. 8.2.3 Oral Vaccines Customers
9 Global Oral Vaccines Analyzing Market Dynamics
  1. 9.1 Oral Vaccines Industry Trends
  2. 9.2 Oral Vaccines Industry Drivers
  3. 9.3 Oral Vaccines Industry Opportunities and Challenges
  4. 9.4 Oral Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst